ESSENTIAL THROMBOCYTHAEMIA side effect
What is ESSENTIAL THROMBOCYTHAEMIA ?Drugs associated with ESSENTIAL THROMBOCYTHAEMIA
BYETTA DOXORUBICIN EPOGEN EXTRANEAL HUMATROPE ORTHO ZANEDIPESSENTIAL THROMBOCYTHAEMIA : Humatrope Side Effects Report #5655451-4
Physician from JAPAN reported HUMATROPE problem on Feb 26, 2008. Female patient was diagnosed with growth hormone deficiency, hypothyroidism, hyperuricaemia and was treated with HUMATROPE. After drug was administered, patient experienced the following problems/side effects: essential thrombocythaemia, white blood cell count increased, . HUMATROPE dosage: 1.4 MG, WEEKLY (1/W). During the same period patient was treated with CORTRIL, THYRADIN S, ACINON, ZYLORIC, URSO, ARTIST. Patient recovered.
ESSENTIAL THROMBOCYTHAEMIA : Zanedip Side Effects Report #5632240-8
ZANEDIP problem was reported by a Physician from ITALY on Feb 12, 2008. Female patient, 72 years of age, was diagnosed with transient ischaemic attack and was treated with ZANEDIP. After drug was administered, patient experienced the following problems/side effects: essential thrombocythaemia, . ZANEDIP dosage: unknown. During the same period patient was treated with ENAPREN, PLAVIX, HIZAAR, LASIX, DILATREND. Patient recovered.
ESSENTIAL THROMBOCYTHAEMIA : Humatrope Side Effects Report #5607465-8
Physician from JAPAN reported HUMATROPE problem on Jan 17, 2008. Female patient was diagnosed with growth hormone deficiency and was treated with HUMATROPE. After drug was administered, patient experienced the following problems/side effects: essential thrombocythaemia, white blood cell count increased, . HUMATROPE dosage: 1.4 MG, WEEKLY (1/W). During the same period patient was treated with CORTRIL, THYRADIN S, URSO, ALLOPURINOL, ACINON, ARTIST. Patient recovered.
ESSENTIAL THROMBOCYTHAEMIA : Extraneal Side Effects Report #5534689-0
EXTRANEAL problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 14, 2007. Female patient, 72 years of age, was diagnosed with peritoneal dialysis and was treated with EXTRANEAL. After drug was administered, patient experienced the following problems/side effects: essential thrombocythaemia, renal failure chronic, skin reaction, . EXTRANEAL dosage: unknown. Patient was hospitalized. Patient died.
ESSENTIAL THROMBOCYTHAEMIA : Doxorubicin Side Effects Report #5571130-6
Consumer or non-health professional from BRAZIL reported DOXORUBICIN problem on Dec 06, 2007. Male patient, 61 years of age, was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: essential thrombocythaemia, . DOXORUBICIN dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISONE. Patient recovered.
ESSENTIAL THROMBOCYTHAEMIA : Ortho Side Effects Report #5529442-8
ORTHO EVRA problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 26, 2007. Female patient was treated with ORTHO EVRA. After drug was administered, patient experienced the following problems/side effects: essential thrombocythaemia, . ORTHO EVRA dosage: unknown. Patient recovered.
ESSENTIAL THROMBOCYTHAEMIA : Epogen Side Effects Report #5466125-7
Pharmacist from UNITED STATES reported EPOGEN problem on Sept 13, 2007. Female patient, 64 years of age, was diagnosed with anaemia and was treated with EPOGEN. After drug was administered, patient experienced the following problems/side effects: essential thrombocythaemia, . EPOGEN dosage: unknown. During the same period patient was treated with TESTOSTERONE. Patient recovered.
ESSENTIAL THROMBOCYTHAEMIA : Doxorubicin Side Effects Report #5614869-6
DOXORUBICIN problem was reported by a Physician from BRAZIL on Jan 21, 2008. Male patient, 61 years of age, was diagnosed with diffuse large b-cell lymphoma stage ii and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase, essential thrombocythaemia, haemoglobin decreased, neutrophil percentage increased, . DOXORUBICIN dosage: unknown. During the same period patient was treated with VINCRISTINE, PREDNISONE, CYCLOPHOSPHAMIDE. Patient recovered.
ESSENTIAL THROMBOCYTHAEMIA : Byetta Side Effects Report #5614752-6
Consumer or non-health professional from UNITED STATES reported BYETTA problem on Jan 28, 2008. Female patient was diagnosed with diabetes mellitus, hypertension, arthritis and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: abdominal distension, blood glucose decreased, essential thrombocythaemia, myeloproliferative disorder, nausea, . BYETTA dosage: unknown. During the same period patient was treated with ACTOS, AVAPRO, VITAMINS, MOBIC. Patient recovered.